Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210

被引:234
作者
Zhang, Guang-ling [1 ,2 ]
Li, Yi-xuan [1 ,2 ]
Zheng, Shu-qi [1 ,2 ]
Liu, Min [1 ,2 ]
Li, Xin [1 ,2 ]
Tang, Hua [1 ,2 ]
机构
[1] Tianjin Med Univ, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China
[2] Tianjin Med Univ, Basic Med Sch, Tianjin 300070, Peoples R China
关键词
miR-199a-3p; miR-210; HBV; HBsAg; Viral replication; PARTICLES; TARGETS; CELLS; LIVER;
D O I
10.1016/j.antiviral.2010.08.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Accumulating evidence suggests that microRNAs (miRNAs) control the replication of both RNA and DNA viruses. In order to determine whether host-encoded miRNAs affect hepatitis B virus (HBV) replication, antisense oligonucleotides (ASOs) of 328 identified human miRNAs were transfected into HepG2 2.2.15 cells, respectively. ELISA and MTS assay were used to measure the expression level of HBV S protein (HBsAg), HBV e antigen (HBeAg) and cell proliferation. Compared to experimental controls, miR-199a-3p and miR-210 efficiently reduced HBsAg expression without affecting HepG2 2.2.15 cell proliferation. Quantification of HBV DNA by real-time PCR showed that both miRNAs suppressed viral replication. Bioinformatics analysis indicated a putative binding site for miR-199a-3p in the HBsAg coding region and a putative binding site for miR-210 in the HBV pre-S1 region. The direct effect of miRNAs on the target region in HBV transcripts was validated by a fluorescent reporter assay, and the suppression of HBs gene expression by both miRNAs was measured by real-time PCR and Western blot. These results suggest that up-regulation of miR-199a-3p and miR-210 in HepG2 2.2.15 cells compared to HepG2 cells may play a role in regulating HBV replication and maintenance of a suitable level of virion production in persistent infection by targeting crucial HBV genes. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 26 条
[11]   Micrornas: Small RNAs with a big role in gene regulation [J].
He, L ;
Hannon, GJ .
NATURE REVIEWS GENETICS, 2004, 5 (07) :522-531
[12]   ViTa: prediction of host microRNAs targets on viruses [J].
Hsu, Paul Wei-Che ;
Lin, Li-Zen ;
Hsu, Sheng-Da ;
Hsu, Justin Bo-Kai ;
Huang, Hsien-Da .
NUCLEIC ACIDS RESEARCH, 2007, 35 :D381-D385
[13]   Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes [J].
Huang, Jialing ;
Wang, Fengxiang ;
Argyris, Elias ;
Chen, Keyang ;
Liang, Zhihui ;
Tian, Heng ;
Huang, Wenlin ;
Squires, Kathleen ;
Verlinghieri, Gwen ;
Zhang, Hui .
NATURE MEDICINE, 2007, 13 (10) :1241-1247
[14]   MicroRNAs in cell proliferation, cell death, and tumorigenesis [J].
Hwang, HW ;
Mendell, JT .
BRITISH JOURNAL OF CANCER, 2006, 94 (06) :776-780
[15]   HBV-encoded microRNA candidate and its target [J].
Jin, Wei-Bo ;
Wu, Fang-Li ;
Kong, Dong ;
Guo, Ai-Guang .
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2007, 31 (02) :124-126
[16]   Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA [J].
Jopling, CL ;
Yi, MK ;
Lancaster, AM ;
Lemon, SM ;
Sarnow, P .
SCIENCE, 2005, 309 (5740) :1577-1581
[17]   A cellular MicroRNA mediates antiviral defense in human cells [J].
Lecellier, CH ;
Dunoyer, P ;
Arar, K ;
Lehmann-Che, J ;
Eyquem, S ;
Himber, C ;
Saïb, A ;
Voinnet, O .
SCIENCE, 2005, 308 (5721) :557-560
[18]   Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line [J].
Liu Yan ;
Zhao Jian-Jun ;
Wang Chun-mei ;
Li Mian-yang ;
Han Ping ;
Wang Lin ;
Cheng Yong-qian ;
Fabien Zoulim ;
Ma Xu ;
Xu Dong-ping .
CHINESE MEDICAL JOURNAL, 2009, 122 (01) :10-14
[19]   HEPATITIS-B VIRAL-DNA RNA HYBRID MOLECULES IN PARTICLES FROM INFECTED LIVER ARE CONVERTED TO VIRAL-DNA MOLECULES DURING AN ENDOGENOUS DNA-POLYMERASE REACTION [J].
MILLER, RH ;
MARION, PL ;
ROBINSON, WS .
VIROLOGY, 1984, 139 (01) :64-72
[20]   miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs [J].
Mourelatos, Z ;
Dostie, J ;
Paushkin, S ;
Sharma, A ;
Charroux, B ;
Abel, L ;
Rappsilber, J ;
Mann, M ;
Dreyfuss, G .
GENES & DEVELOPMENT, 2002, 16 (06) :720-728